Telesis Bio

🚨 We’re hiring! Join us at the forefront of DNA synthesis and synthetic biology innovation. At Telesis Bio, we’re building the future with Gibson SOLA, a breakthrough enzymatic DNA synthesis platform accelerating discovery in antibody engineering and mRNA therapeutics. We're looking for two key team members: 🔹 Senior Product Marketing Manager Own and amplify our messaging, drive awareness in antibody discovery, and fuel our GTM efforts with impactful content and campaigns. 🔹 Product Manager Lead the product roadmap, optimize performance, and define the next generation of SOLA platform features with a focus on scientific impact and technical rigor. 👉 Know someone who’d be a great fit? Let’s connect! #productmarketing #productmanagement #DNAsynthesis #syntheticbiology #nowhiring #biotechcareers #GibsonSOLA https://lnkd.in/gVmCEiuK https://lnkd.in/gRtprVBC

Drug discovery is moving faster - and the tools behind it need to keep up. From AI-generated constructs to rapid prototyping and screening, modern drug development demands precision and speed. The Gibson SOLA Platform delivers both. Explore how SOLA helps teams turn early ideas into engineered solutions - faster than ever: 👉 https://lnkd.in/gR5fHRzt #DrugDiscovery #SyntheticBiology #BiotechInnovation #PharmaTools #GibsonSOLA #TelesisBio #SpeedToInsight

AI is changing the pace of discovery - and synthetic biology is changing what’s possible. At the frontier of science, researchers are designing life from the ground up: solving complex problems and reimagining what biology can do. The Gibson SOLA Platform gives scientists the power to rapidly test and iterate AI-generated designs - faster, cleaner, and at scale. Explore how synthetic biology and AI are converging to help scientists craft the future: 👉 https://lnkd.in/gviPrgRZ #AIinBiotech #SyntheticBiology #CraftingLife #TelesisBio #GibsonSOLA #FutureOfPharma #BiotechInnovation

The future of pharma isn’t coming - it’s already being built. At Telesis Bio, we’re rethinking how complex DNA assembly fits into fast-moving drug development. The Gibson SOLA platform is more than a new tool - it’s a shift in what’s possible. From bench to biomanufacturing, SOLA helps teams: ✅ Cut build times ✅ Streamline workflows ✅ Push the limits of synthetic biology This isn’t a vision - it’s happening now. 👉 https://lnkd.in/ga4NTQ_i #SyntheticBiology #PharmaInnovation #DNABuilding #TelesisBio #FutureOfPharma #BiotechTools

🧬 We’re honored — and a little speechless. Nature BioPharma sat down with our CEO to talk about something that matters deeply to us: accelerating biology without the bottlenecks. In this wide-ranging interview, they covered: - How synthetic biology is evolving in the age of AI - Why control over your DNA synthesis matters more than ever - And how platforms like Gibson SOLA are reshaping what's possible in R&D A huge thank you to the editors at Nature BioPharma Interviews for spotlighting this work and the scientists who are making it real every day. 🔗 Read the full interview here https://lnkd.in/g22xrcdG #SyntheticBiology #AIinBiotech #GibsonSOLA #DNAonDemand #TelesisBio #NatureBioPharma

Control the molecule. Control the pipeline. When Regeneron adopts a technology, the industry takes note. We’re proud to announce a licensing agreement that brings Telesis Bio’s Gibson SOLA™ platform to Regeneron’s core R&D facilities. That means: internalized synthesis. On-site agility. Enhanced data security. And a serious speed advantage. This collaboration is part of a larger movement where leading biopharma companies are taking nucleic acid production into their own hands to drive AI-powered discovery and reduce external dependencies. The Gibson SOLA platform delivers: �� Fully enzymatic, high-fidelity synthesis ✅ Overnight turnaround ✅ Seamless integration with existing lab automation We're not just speeding up workflows. We're shifting the paradigm. telesisbio.com/sola Check out the press release here: https://lnkd.in/gmgTXP82 #LifeSciences #BiotechInnovation #SyntheticBiology #OnDemandDNA #Regeneron #TelesisBio

Big news from the Telesis Bio team! We just released a brand-new free eBook - in collaboration with GEN - that dives into advances in synthetic biology, automation, and how AI is expanding what is possible in biotech. "Breaking the Bottleneck: On-Demand Biology in the Age of AI" explores how scientists are now able to design, build, and test biological systems faster than ever thanks to powerful machine learning models and platforms like our Gibson SOLA. This isn’t just a glimpse into the future of R&D - it’s a front-row seat. If you’re curious about what’s next for drug discovery, protein engineering, or even agriculture, grab a cup of coffee and download the free eBook. You’ll walk away with fresh insights on how AI and automation are solving some of the biggest bottlenecks in the lab. https://lnkd.in/dgW6VSvC #digitalbiology #gibsonsola #telesisbio #AIinbiology

🚀 What happens when DNA synthesis gets faster, cleaner, and completely under your control? Our CEO, Eric Esser, sat down with Nature to talk about Gibson SOLA — our enzymatic DNA synthesis platform that’s changing how scientists build genes. If you care about turnaround times, sequence fidelity, or getting your research moving faster — don’t miss this one. 👉 https://lnkd.in/gV-JwMVf #DNAonDemand #GibsonSOLA #SynBio #BiotechInnovation #NatureInterview #TelesisBio #DNAinaDay

Own Your Process. Own Your Progress! Take control of DNA and mRNA synthesis. Join David Weiss on Wednesday May 14th at 12:00 pm at the Protein and Antibody Engineering Summit (PEGS) in Boston to explore how the Gibson SOLA Platform empowers researchers to build biology overnight. Our special guest, John Fuller from Beckman Coulter Life Sciences, will give a bonus talk on how to rapidly automate the process. Stop waiting. Start building. #PEGS2025 #TelesisBio #LabAutomation #BeckmanCoulterLifeSciences

Own Your Process. Own Your Progress! The future of DNA synthesis is in your hands. Join David Weiss on Wednesday April 23rd at 11:55 am at The World Vaccine Congress in Washington D.C. to explore how the Gibson SOLA Platform empowers researchers to build biology overnight. Stop waiting. Start building.